Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCD-2101 for Functional Constipation in the Elderly
NCT06534996Recruiting
- Sponsor
- Hong Kong Baptist University
- Start
- Aug 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of mazirenwan in functional constipation (FC), sponsored by Hong Kong Baptist University. Primary endpoint: Response rate of Complete Spontaneous Bowel Movements (CSBM) at 2 weeks. Started Aug 2024; status: recruiting.
02
Drugs
mazirenwan
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on NCT06534996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06534996.